Company profile: Lymphatica Medtech
1.1 - Company Overview
Company description
- Provider of medical device development, creating a minimally invasive solution for chronic lymphedema.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Lymphatica Medtech
Cero Therapeutics
HQ: United States
Website
- Description: Provider of cellular immunotherapy centered on a CER T-cell platform that integrates anti-tumor capabilities of the innate and adaptive immune systems into a single T cell, aimed at treating hematologic malignancies and solid tumors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cero Therapeutics company profile →
Endevica Bio
HQ: United States
Website
- Description: Provider of biotechnology therapeutics for cachexia and obesity via melanocortin receptor modulation. Offerings include TCMCB07 (B07), a clinical-stage MC3R/MC4R antagonist to treat cancer-related uncontrolled weight loss, shown to increase body weight in chemotherapy and CKD models; MC4R agonists for obesity matching GLP-1 weight loss efficacy in rats without significant weight rebound post-treatment; and novel synthetic peptidomimetics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endevica Bio company profile →
Med BioGene
HQ: Canada
Website
- Description: Provider of life science-focused genomic-based clinical lab development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Med BioGene company profile →
Mitomics
HQ: Canada
Website
- Description: Provider of mitochondrial genome-based molecular tests to improve clinical insight and therapeutic decisions that affect patients worldwide, leveraging unparalleled insights into mitochondrial DNA (mtDNA) to develop an extensive, proprietary portfolio.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mitomics company profile →
Kura Oncology
HQ: United States
Website
- Description: Provider of precision medicines for solid tumors and blood cancers, advancing investigational therapies including ziftomenib for AML with specific mutations, tipifarnib for HRAS-mutant head and neck squamous cell carcinoma and other cancers, and KO-2806, a next-generation FTI for advanced solid tumors; also conducts clinical trials and offers expanded access programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kura Oncology company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Lymphatica Medtech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Lymphatica Medtech
2.2 - Growth funds investing in similar companies to Lymphatica Medtech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Lymphatica Medtech
4.2 - Public trading comparable groups for Lymphatica Medtech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →